Equity Clock

Arithmetic Average Seasonal Chart

Geometric Average Seasonal Chart

GRCE Relative to the S&P 500

GRCE Relative to the Sector

% of Free Cash Flow Generated in Each Quarter

% of Net Income Generated in Each Quarter

Seasonal Chart Analysis

Analysis of the Grace Therapeutics, Inc. (NASD:GRCE) seasonal charts above shows that a Buy Date of November 27 and a Sell Date of February 17 has resulted in a geometric average return of 1.06% above the benchmark rate of the S&P 500 Total Return Index over the past 14 years. This seasonal timeframe has shown positive results compared to the benchmark in 9 of those periods. This is a fair rate of success and the return strongly outperforms the relative buy-and-hold performance of the stock over the past 14 years by an average of 40.97% per year.

The seasonal timeframe correlates Poorly with the period of seasonal strength for the Healthcare sector, which runs from April 25 to December 4. The seasonal chart for the broad sector is available via the following link: Healthcare Sector Seasonal Chart.

Grace Therapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of pharmaceutical applications of its licensed rights for cardiovascular diseases. It focuses on the research of prescription drugs using omega-3, fatty acids derived from krill oil. The company was founded by Henri Harland and Pierre Lemieux on February 1, 2002 and is headquartered in Princeton, NJ.

To download GRCE seasonal chart data, please log in or Subscribe.

Stocks mentioned in this post: GRCE